The gut–liver axis in progressive steatotic liver disease: A focus on bile acid dysregulation

Taurocholate and taurochenodeoxycholate emerge as consistent BA markers across liver disease stages, suggesting BA metabolism as potential therapeutic targets. This multi-model study bridges knowledge gaps in BA-driven mechanisms, informing personalised strategies for SLD management.

Authors

Institutions

Publication Details

Journal
The journal of nutrition health & aging
Published
2025-09-04
DOI
https://doi.org/10.1016/j.jnha.2025.100671
Citations
1
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
1.35

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The gut–liver axis in progressive steatotic liver disease: A focus on bile acid dysregulation

Joanna Simpson, Panayiotis Louca, Francisco Javier Cubero, Ana M. Valdes et al.
1 citations
The journal of nutrition health & aging
Liver Disease Diagnosis and Treatment
1.35
article

The gut–liver axis in progressive steatotic liver disease: A focus on bile acid dysregulation

Joanna Simpson, Panayiotis Louca, Francisco Javier Cubero, Ana M. Valdes, Olga Estévez‐Vázquez, María Martínez-Gómez, Juan M. Pericàs, Natalie Z M Homer, Afroditi Kouraki, Cristina Menni, Yu Lin, M Serra Cusidó
article en
1 citations

Abstract

Taurocholate and taurochenodeoxycholate emerge as consistent BA markers across liver disease stages, suggesting BA metabolism as potential therapeutic targets. This multi-model study bridges knowledge gaps in BA-driven mechanisms, informing personalised strategies for SLD management.

The journal of nutrition health & agingVol. 29(11)
Hebron University (PS), Nottingham University Hospitals NHS Trust (GB), King's College London (GB), Nottingham City Hospital (GB), Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT), Vall d'Hebron Institut de Recerca (ES), Vall d'Hebron Hospital Universitari (ES), Nottingham Biomedical Research Centre (GB), Medical Research Network (US), The Queen's Medical Research Institute (GB)
Wellcome Trust, UK Research and Innovation, Dipartimenti di Eccellenza, National Institute for Health and Care Research, British Heart Foundation, European Commission, Ministero della Salute, Horizon 2020 Framework Programme, HORIZON EUROPE Framework Programme, Medical Research Council, Agencia Estatal de Investigación, NIHR Nottingham Biomedical Research Centre
Openalex Percentile: Top 16%
Liver Disease Diagnosis and Treatment
1.35
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.